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the Division of 
Neurosciences (Department of Medicine) 
and the Division of Vascular Surgery on 
the NIH announcement regarding ACAS. 
This report represents a major advance 
in health care and our hospital/medical 
staff represented the leading institution 
for patient enrollment. This is a major 
accomplishment of which we certainly 
can all feel proud. 
Also, I am pleased to report that 
Ingersoll Rand has selected Lehigh 
Valley Hospital as one of its centers for 
cardiac care. We represent one of six 
institutions nationwide to be selected. 
Kudos to the Cardio-thoracic Surgeons, 
Cardiologists and Administration. 
Recent appointments for the Clinical 
Assistant Professorship at Penn State 
have recently been announced. Our 
congratulations to those clinicians so 
honored. 
At the Medical Executive Committee, we 
have been reviewing the issues of 
physician-physician, physician-hospital 
and hospital- physician responsibilities 
and commitment. Also, as I have 
mentioned in the past, John VanBrakle, 
M.D. and I co-chair a subcommittee 
addressing these issues. One very 
important issue continues to be the need 
for mutual communication grounded in 
fact. We shall begin forums for 
discussions regarding issues of concern 
to both the Medical Staff and 
Administration. These meetings will be 
led by TROIKA and Elliot Sussman, 
M.D., President and CEO, and Louis 
Liebhaber, COO. The flrst meeting is 
planned for early November. We're 
working on the arrangements and format 
and Will provide further information. 
A questionnaire will soon be sent to the 
entire Medical Staff. This questionnaire 
centers on issues of responsibility 
mentioned above. I believe this to be an 
important means of gaining and sharing 
data essential for the further growth and 
development of the Medical Staff of 
Lehigh Valley Hospital. I ask that you 
seriously consider these questions, 
providing thoughtful and meaningful 
answers. 
It is with great sadness that we note the 
passing of George Moerkirk, M.D. 
George's accomplishments helped to 
ensure quality emergency medical care 
for our community, and provide a 
continuing legacy to this great man. Our 




President, Medical Staff 
Site and Facilities Update 
Cedar Crest & 1-78 
Roadwork to Result in Added Safety, 
Access and Convenience · 
Lehigh Valley Hospital is initiating and 
funding a project that will ease the 
flow of traffic and improve automotive 
safety along Cedar Crest Boulevard 
and the hospital's main access road. 
"The project, which will be completed 
in six phases, is designed to alleviate 
the congestion that makes driving 
conditions less than ideal for hospital 
and general traffic," says Ken Erland, 
Vice President, Facilities and 
Construction. 
Phase 1 
Contractors have completed Phase 1 of 
the project which included the removal 
of a median at the entrance to the 
hospital's main access road and two 
islands that allow ·drivers to ease off 
Cedar Crest Boulevard and onto the 
hospital campus or the 1243-1251 
office buildings. 
Phase 2 
The second phase of the project began 
September 30 and will continue 
through October 27. During this time, 
a section of Cedar Crest Boulevard, 
extending north of the hospital to the I-
78 exit ramp and south to Fish 
Hatchery Road, will be widened. 
Phase 3 (October 25-30) 
Phase 3 will begin as Phase 2 draws to 
a close and continue fr<?m 9 p.m. to 6 
a.m. daily. During this time, the 
intersection of the hospital's main entry 
drive and Cedar Crest Boulevard will 
be widened to facilitate traffic flow 
into and out of the hospital campus. 
Phase 4 (October 17- November 11) 
Concurrent with Phase 3, contractors 
will proceed with Phase 4 and plans to 
widen the inbound and outbound m~ 
and south access roads to the hospital. 
Phase 5 (November 12-30) 
During Phase 5, a median will be 
installed in the center of the hospital's 
main access road along with two 
islands to ease traffic in and out of the 
hospital. 
Phase 6 (April 1995) 
The project will blsuspep.ded during 
the winter months and resume in April 
1995 for the final phase wheri'':the 
Cedar Crest Boulevard southbound.left-
turn lane will be extended. 
Administrative Offices Relocate 
Senior management has relocated to 
new offices on the third floor of the 
Anderson Wing. Personnel involved in 
the move and their new extensions 
include: 
Elliot J. Sussman, M.D., Ext. 7500 
Regina M. Jones, Ext. 7500 
Audrey L. Lauer, Ext. 7500 
Vaughn C. Gower, Ext. 7510 
Mary T. Kinneman, Ext. 7510 
Linda L. Moyer, Ext. 7510 
(Continued on Page 3) 
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Louis L. Liebhaber, Ext. 7515 
Thomas H. Hansen, Ext. 7515 
Carolyn Trauger, Ext. 7515 
Joseph A. Candio, M.D., Ext. 7520 
John C. Stavros, Ext. 7520 
Joan E. Sweeney, Ext. 7520 
All mail for senior management should 
be forwarded to the Management Suite 
with the exception of Dr. Candio; his 
mail should continue to be forwarded 
to his practice office at CCMOB1230, 
Suite 201, or to the Medical Staff 
Services Office, Cedar Crest & I-78. 
Renovations Proceeding on Nursing 
Offices 
Renovations are in _progress for new 
nursing administration and staffing 
offices in the area previously occupied 
by Human Resources. The project is 
scheduled for completion this month. 
Concurrently, offices and departments 
surrounding the existing annex and 
admini~trative offices are being 
relocated so renovations can begin in 
the GI Lab and Pre-admission Testing. 
Lithotripsy Addition, Angiography 
Room Completed 
Construction has been completed on an 
extension of the lithotripsy area 
adjacent to the shock/trauma unit, 
including the addition of a dock to 
facilitate transport of the portable 
lithotripter. Meanwhile, a second 
angiography room has been added to 
the Radiology Department in space 
previously occupied by a special 
procedures room. The lithotripsy 
addition has already been evaluated and 
passed inspection by state officials. 
Official Address Prevents Delays 
The official mailing. address for Lehigh 
Valley Hospital, Cedar Crest & I-78, 
including hospital departments at 1240 
S. Cedar Crest.Blvd., is P.O. Box 
689, Allentown, PA 18105-1556. 
Mail addressed to 1200 or 1240 S. 
Cedar Crest Blvd. is forwarded to a 
post office outside of Allentown. To 
avoid unnecessary delays in mail 
delivery, please be sure to use the 
correct address. 
17th & Chew 
State Okays Transitional Unit 
The State Department of Health has 
approved the hospital's plans to open a 
transitional or sub-acute care unit for 
elderly and disabled patients. The 
unit, which will accommodate 52 
p~tients on the fifth floor of the 
hospital, will serve medically-stable 
patients who no longer require acute 
care but are not well enough to be 
discharged home or transferred to a 
nursing home. Similar but smaller 
units are already operating at capacity 
at Muhlenberg, St. Luke's, and Sacred 
Heart Hospitals. 
Access Limited to Schaeffer Wing 
The second floor Schaeffer Wing, from 
the white elevator at the west end of 
the Trexler Wing to the former Dental 
Service, has been closed for 
renovations that will continue through 
early December. Emergency egress 
signs have been posted at each end of 
the construction area. 
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Dental Service Relocates 
The Dental Service, including the 
dental clinic, laboratories and 
administrative functions, has relocated 
to newly-renovated quarters on 1N, the 
former OTU/Bxpress Care area. Calls 
regarding patient care and continuing 
education should be directed to Pat 
Atno, supervisor, at 402-2245, while 
information about the residency 
program is available through Linda, the 
dental secretary, Monday through 
Friday, from 8:30a.m. to 12:30 p.m., 
at 402-9636. To reach Dr. 
Incalcaterra, Assistant Residency 
Program Director, please call 
402-2910. 
Outpatient Testing to be 
Consolidated 
Also on the first floor, renovations are 
proceeding on schedule for a unit that 
will consolidate outpatient diagnostic 
services including BEG, EKG, 
Respiratory Therapy, Pulmonary 
Function, and Heart Station. 
However, to facilitate the ambulatory 
surgery project, BEG, EKG, 
Respiratory Therapy, and Heart Station 
have been temporarily relocated to the 
ICU since the outpatient testing unit 
will not be completed until mid-
October. 
New Ambulatory Surgery Unit to 
Open 
On the second floor Tower, 
renovations are proceeding on the pre-
admission testing area and ambulatory 
surgery (short procedure) unit that will 
adjoin the Operating Room suites. 
Speech Pathology Update 
Callie McClatchy and Cheryl Laky, 
director and secretary, respectively, of 
the Speech Pathology Department, 
have relocated to Cedar Crest & I-78 
between 4A and 4C and are available 
to address administrative issues 
regarding this service at 402-5095. 
Appointments for outpatients can also 
be scheduled by calling this extension. 
However, actual outpatient treatment 
will be provided in Room 5S03, 17th 
& Chew, at 402-2544. Meanwhile, 
Patti Schlegel, Melanie Jozefiak, and 
Denise Wolst, speech pathologists, can 
be reached at 402-1665, sixth floor, 
Cedar Crest & l-78. 
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Upcoming JCAHO Survey - Medical Staff Members to 
be Questioned on Patient Care Units 
The Joint Commission on Accreditation 
of Healthcare Organizations (JCAHO) 
will be visiting the hospital from 
November 3 through 9 to conduct a 
survey of hospital services and 
operations. Held every three years, 
the purpose of the survey is to 
determine if the hospital is in 
compliance with its standards and 
providing high quality patient care. 
The survey team is typically comprised 
of a physician, a nurse, and an 
administrator. The team will review 
hospital and medical staff records 
pertaining to credentialing and 
privileging, performance improvement 
(formerly referred to as quality 
assurance), infection control, plant 
technologies and safety management, 
information management, and patient 
assessment and education, among 
others. 
An important new element of this 
year's survey is the JCAHO's focus on 
not just whether the hospital has 
policies and procedures in place, but 
also whether hospital personnel, the 
medical staff, the allied health staff, 
and volunteers are knowledgeable of 
the policies and procedures, and 
whether those policies and procedures 
are being carried out. To that end, 
surveyors will be stopping caregivers 
on the units (IT COULD BE YOU) to 
ask questions pertaining to the 
hospital's mission statement, 
procedures for fire safety, bomb 
threats, identification and handling of 
hazardous materials, documentation of 
patients' charts, the hospital's 
performance improvement process, and 
whether there are any specific 
performance improvement projects 
underway in that particular area. 
Further, the surveyors will also be 
asking patients questions to determine 
whether the staff is actually carrying 
out its policies related to patient 
education and patient rights. 
To assist you in answering some of 
these questions, the Safety Office has 
ordered laminated cards designed to be 
worn with your J.D. badge. These 
cards contain the following 
information: the telephone number to 
call for all emergencies (555), names 
of codes and their definitions (e.g., 
Code Blue), and a chart of the 
hazardous materials identification 
system. These cards are expected to 
be delivered to you the week of 
October 17. If you need additional 
information about these cards, please 
contact the Safety Office at 402-8518. 
In addition, the reverse side of your 
I.D. badge states the hospital's mission 
and values statements. 
Your participation in this survey 
process is a very significant portion of 
the overall scoring for the hospital, and 
your cooperation is very much 
appreciated. If you have any questions 
or concerns regarding this issue, please 
call Medical Staff Services at 
402-9850. 
(Continued on Page 6) 
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Tips to Assist You to Prepare for 
JCAHO 
• Attach the laminated safety cards to 
your J.D. badge when you receive 
them, and wear your J.D. badge 
whenever you are in the hospital 
facilities. 
• Become familiar with the placement 
of fire extinguishers and escape routes 
for each of the patient care units you 
frequent. 
• Talk to the staff nurses about any 
performance improvement projects 
which may be underway on those units 
you frequent. 
• If a surveyor asks you questions, 
phrase your answers in a positive 
manner and provide only the 
information requested. 
• Remember that although you may 
not know the specifics of a given 
policy or procedure, if you can show 
that you know where the policy manual 
is located in the nurses' station, that 
answer will be sufficient. 
Changes in Admitting Functions During Night Shift 
Effective October 17, 1994, processing 
of admissions, bed assignments, body 
releases, and all other functions 
currently performed by the Inpatient 
Admission Office at Cedar Crest & 
1-78 during the night shift, will be 
performed by the Emergency 
Department Registration Office at 
Cedar Crest & 1-78. 
All processes will be transferred from 
the Inpatient Admission Office to the 
Emergency Department Registration 
Office at 11 p.m. each night, and will 
be returned at 5 a.m., Monday through 
Friday, and at 7 a.m., Saturday and 
Sunday. 
If, at any time, you have questions 
regarding admissions or related 
information, please continue to call the 
Admitting Department at 402-8061. 
If you have questions regarding this 
issue, please contact John Horoski, 
Director, Access Services, at 
402-8202, or Andrew Meyers, 
Supervisor, Inpatient Admitting, at 
402-4296. 
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Observation Bed Status Update 
Some physicians and hospital staff have 
requested an update and reminder of 
protocols for use of Observation Bed 
Status. Some important points to 
remember include: 
• Medicare regulations as well as 
hospital policy require that observation 
status not exceed 24 hours. 
• The physician must write an order 
to assign the patient to observation 
status. 
• A decision must be made within 24 
hours to discharge the patient or to 
admit as an inpatient. 
Appropriate candidates include: 
• Patients whose anticipated stay is 
less than 24 hours. 
• Patients whose ambulatory stay may 
exceed 14 hours. 
• Patients who need evaluation and 
treatment until the acuity of their 
condition can be established. 
Inappropriate Use of Observation 
Beds: 
• Convenience of patient, family or 
physician. 
• Custodial care. 
• Conditions routinely treated as an 
outpatient. 
• Acute psychiatric problems. 
• Criteria for inpatient admission is 
met. 
If you have any questions regarding 
observation status, please feel free to 
call Arline Connors, Manager, 
Resource Utilization Management, at 
402-8604. 
Clinical Trials Available for HIV Patients 
The hospital was recently contacted by 
the AIDS Clinical Trials Unit of the 
University of Pennsylvania with an 
update of Clinical Trials available in 
the Philadelphia area. These studies 
focus on adult patients with HIV and 
address varied concerns including 
prophylaxis, opportunistic infections, 
anti-retroviral therapy, nutrition, and 
women's health issues. Please 
consider if your HIV patients might 
benefit from a referral to one of these 
studies. 
For more information regarding these 
Clinical Trials, please contact the 
AIDS Activities Office at 402-2400. 
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Fifth Annual Prostate Screening a Huge Success 
With over 1,450 participants, the Fifth 
Annual Prostate Screening Program 
was held on September 17, 19, 22 and 
24, at the John and Dorothy Morgan 
Cancer Center. 
The free screening program, which is 
sponsored by the Morgan Cancer 
Center, consists of prostate specific 
antigen (PSA) blood work being drawn 
and a digital rectal exam performed by 
a physician. All participants receive 
follow-up letters with those screening 
results. Participants with abnormal 
results receive follow-up telephone 
calls as well as the follow-up letter. 
With an increase of over six times the 
response as last year, this year's 
program resulted in the addition of two 
extra screening dates. 
Coordinating this year's program 
included: Richard M. Lieberman, 
M.D., and Edward M. Mullin, Jr., 
M.D., Co-Unit Directors, 
Genitourinary Oncology, Morgan 
Cancer Center; Lori BarreD, R.N., 
M.S.N., O.C.N., Oncology Nurse 
Educator, Morgan Cancer Center; and 
Historical Archives 
The Historical Archives is seeking 
pictures, instruments, and any other 
memorabilia that will illuminate the 
past of Lehigh Valley Hospital or of 
medicine and its specialties. Any 
contributions will be a significant 
addition for displays. The preservation 
and exhibition of materials from the 
past will make possible a deeper and 
Sharon Boley, Manager, Peripheral 
Sites Coordinator, Health Network 
Laboratories. 
The success of the program was made 
possible through the efforts of the 
following physicians who volunteered 
their time and expertise: David L. 
Clair, M.D., Arthur E. Fetzer, 
M.D., Jeffrey L. Gevirtz, M.D., 
John S. Jaffe, M.D., Richard M. 
Lieberman, M.D., Edward M. 
Mullin, Jr., M.D~, Brian P. Murphy, 
M.D., Joseph Pascal, M.D., Daniel 
M. Silverberg, M.D., and Robert 
Wasko, M.D., Division of Urology; 
Headley S. White, Jr., M.D., 
Chairperson, Department of Family 
Practice; John P. Fitzgibbons, M.D., 
Chairperson, Department of Medicine; 
David Prager, M.D., Director, 
Morgan Cancer Center; and Joseph A. 
Candio, M.D., and Paul Guillard, 
M.D., Division of General Intema1 
Medicine. 
In addition, 63 staff members from 
nursing, administration, laboratory, 
and clerical provided their assistance. 
fuller understanding of medicine and 
Lehigh Valley Hospital's role in the 
history of health care in the Lehigh 
Valley. 
If you have any questions or materials 
to donate, please call Joanne Mortimer, 





One of the most frequently asked 
questions received in the Department 
of Legal Services/Risk Management 
deals with the reporting obligation of 
physicians for impaired drivers. 
The Pennsylvania Motor Vehicle Code 
requires that physicians promptly 
report to the Pennsylvania Department 
of Transportation (PennDOT) the 
identity of any person over 15 years of 
age diagnosed as having a condition 
that could impair a driver's ability to 
drive. The report must be made in 
writing and be submitted to PennDOT 
within 10 days after the physician's 
contact with the patient. 
Reports can be made by letter or by 
using PennDOT' s Initial Reporting 
Library News 
Computerization Status 
The Library is currently in the process 
of testing several library systems on 
the Hospital Wide Network. Orice 
these systems are tested in a series of 
phases and all the "bugs" are worked 
out, they will be available from all the 
hospital on-site and remote access 
workstations. Included are: 
MICROMEDEX, a clinical 
information system consisting mainly 
of drug and poison information. The 
third stage of testing has begun, and 
there are a few operational problems to 
work out. 
Form, which can be obtained from the 
department. When reporting, you 
should include the patient's full name, 
address, and date of birth. Also, 
describe the condition and any specific 
information about the condition which 
will help the department make a 
licensing decision. Send your letter or 
the reporting form to: Bureau of Drive 
Licensing, Driver Qualification 
Section, Pennsylvania Department of 
Transportation, P.O. Box 68682, 
Harrisburg, PA 17106-8682. 
Physicians who have questions or need 
more information about PennDOT's 
reporting requirements or the Medical 
Advisory Board should call Anne 
Petrucci Titler at (717) 783-6246. 
CD Plus OVID, the main databases 
being MEDUNE and HEALTH, is 
currently being converted by the 
vendor to be compatible with our 
network server. It will then be 
installed on-site and testing will begin. 
Remember, these databases are 
currently available in the Library on 
standalone CD ROM systems. These 
systems will be available 24 hours 
daily until the transition to the network 
is completed. 
If you have any questions or would 
like more information, please contact 
Sherry Giardiniere, Library Computer 
Coordinator, at 402-8406. 
Continued on Page 1 0 
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New Acquisitions 
New acquisitions to the Health 
Sciences Library at 17th & Chew 
include: 
Orr. Complications in Gynecologic 
Surgery. Lippincott, 1994. 
Baden. Surgical Repair of Vaginal 
Defects. Lippincott, 1992. 
Baum. Marketin& Your Clinical 
Practice: Ethically, Effectively, 
Economically. Aspen, 1992. 
Behrman. Nelson Essentials of 
Pediatrics. 2nd ed. Saunders, 1994. 
News from Research 
1994 Yearbook of Staff 
Publications 
Once again, the Research Department 
is requesting articles for the purpose of 
compiling another staff publications 
yearbook. The articles for the new 
yeatbook should fall between the dates 
of January 1994 and December 1994, 
however, publications as early as 
January 1986 will be considered if they 
were not previously submitted. 
In an effort to make this yearbook as 
complete and accurate as possible, the 
Research Department requests a reprint 
or citation of Lehigh Valley Hospital 
employees and medical staff 
publications which meet the following 
criteria: 
New acquisitions at Cedar Crest & I-78 
include: 
Sloane. &sentials of Famlly 
Medicine. 2nd ed. Williams, 1993. 
Goroll. Primary Care Medicine. 3rd 
ed. Lippincott, 1994-95. 
McClatchey. Clinical Laboratory 
Medicine. Williams, 1994. 
DeGroot. Endocrinology. 3 vols. 3rd 
ed. Saunders, 1995. 
• The article is medically/scientifi~y 
oriented; published in a refereed/peer 
reviewed journal 
• Published between January 1994 to 
December 1994 
• Published as an abstract, journal 
article, book chapter, or letter to the 
editor 
• The author or one of the authors was 
a staff member of Lehigh Valley 
Hospital between January 1994 to 
December 1994 
Please forward your reprints or 
citations to Kathleen Moser, Research 
Department, at your earliest 
convenience. 
Continued on Page 11 
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A copy of the table of contents of the 
first five yearbooks is available for 
your review in the Research 
Department. 
For more information, please contact 
Kathy in the Research Department at 
402-8747. 
Call for Abstracts 
A call for abstracts has been issued by 
the following organizations: 
• The American College of Surgeons 
Committee on Trauma Annual Meeting 
to be held on May 4, 1995 in Boston, 
Mass. Submission due date is 
November 15, 1994. 
• The American College of Surgeons 
Committee on Trauma for the Resident 
Trauma Paper Competition to be held 
on May 4, 1995 in Boston, Mass. 
Submission due date is November 15, 
1994. 
• The American Society of Colon and 
Rectal Surgeons Annual Meeting to be 
held on May 7, 1995 in Montreal, 
Canada. Submission due date is 
November 1, 1994. 
• The Society for Clinical Trials 16th 
Annual Meeting to be held on April 
30, 1995 in Seattle, Wash. Submission 
due date is December 1, 1994. 
• The Society for Pediatric Research 
Annual Meeting to be held on May 8, 
1995 in San Diego, Calif. Submission 
due date is January 4, 1995. 
• The American Academy of Family 
Physicians Annual Meeting to be held 
on September 19, 1995 in Anaheim, 
Calif. 
• The American Psychiatric 
Association Annual Meeting to be held 
on May 20, 1995 in Miami Beach, Fla. 
• The American Society of Plastic and 
Reconstructive Surgery Annual 
Meeting to be held on October 7, 1995 
in Montreal, Canada. 
For instructions, forms, and further 
information, please contact Kathleen 




David G. Beckwith, Ph.D., 
Administrator and Clinical Director, 
Health Network Laboratories, was 
appointed by Northampton County 
Executive, A. Landis Brackbill, to 
serve on a team charged with 
investigating options for the creation of 
a County Bureau of Health. 
Joseph A. Candio, M.D., and Robert 
J. Kovacs, M.D., general internists, 
were recently informed by the 
American Board of Internal Medicine 
that they pasSed the Geriatric Medicine 
examination and have been awarded 
Certificates of Added Qualifications in 
Geriatric Medicine. 
Larry R. Glazerman, M.D., and 
Howard M. Listwa, D.O., 
Department of Obstetrics and 
Gynecology, were recently recertified 
by the American Board of Obstetrics 
and Gynecology. 
Yehia Y. Mishriki, M.D., Director of 
Ambulatory Care, received the Dean's 
Special Award for Excellence in 
Clinical Teaching at Lehigh Valley 
Hospital at the commencement 
exercises of the Hahnemann University 
School of Medicine. · 
Raymond L. Singer, M.D., 
cardiothoracic surgeon, was recently 
certified by the American Board of 
Thoracic Surgery in the specialty of 
Thoracic and Cardiac Surgery. 
Publications, Papers and Presentations 
David G. Beckwith, Ph.D., 
Administrator and Clinical Director, 
Health Network Laboratories, was a 
speaker at the annual meeting of the 
Pennsylvania Association of 
Practitioners in Infection Control which 
was held in Harrisburg on September 
16. His topic was Application of 
Molecular Microbiology Techniques 
to the Epidemiology of Nosocomial 
Infection. 
Herbert L. Hyman, M.D., 
gastroenterologist, was a guest speaker 
at a primary care seminar on October 5 
at Sacred Heart Hospital. His topic 
was The Irritable Gut Syndrome. 
Peter A. Keblish, M.D., chief, 
Division of Orthopedic Surgery, was a 
guest lecturer and moderator of the 
Mobile Bearing Total Knee Learning 
Center at Baptist Memorial Medical 
Center in Little Rock, Ark. Dr. 
Keblish presented several subjects on 
total knee arthroplasty. 
Glen L. Oliver, M.D., 
ophthalmologist, presented a paper, 
Garamycin Toxicity of the Macula, at 
the Wills Eye Hospital annual 
Fluorescein Conference on September 
22. 
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Upcoming Seminars, Conferences and Meetings 
Regional Symposium 
Series VI 
Cancer Update 1994: Ovarian 
Cancer will be held on Friday, 
October 21, from 8 a.m. to 3:30p.m., 
in the Auditorium of Lehigh Valley 
Hospital, Cedar Crest & 1-78. 
Individuals who may benefit from this 
program include gynecological 
oncologists, gynecologists, oncologists, 
radiation oncologists, general · 
practitioners, nurses, social workers, 
radiation technicians, tumor registrars, 
and other health care professionals 
interested in ovarian cancer. 
At the completion of this program, 
participants should be able to: 
• identify means for the early 
detection of ovarian cancer 
• discuss the state of the art treatment 
modalities for ovarian cancer 
• identify the benefits and potential 
outcomes of each of the major 
treatment mod3.lities. 
Provider Responsibilities in Managed 
Care ••• Do You Follow the Rules or 
Write the Rules? will be held on 
Saturday, November 5, from 7 a.m. to 
12:30 p.m., in the Auditorium of 
Lehigh Valley· Hospital, C~ar Crest & 
I-78. 
Physicians, nurses, and other health 
professionals interested in provider 
responsibilities in managed care will 
benefit from the program. 
At the completion of this program, 
participants should be able to: 
• describe provider responsibilities to 
the community as they relate to 
managed care 
• discuss the social contract between 
the patient and the provider as it relates 
to managed care 
• explain the effects of managed care 
as it relates to efficiencies, quality and 
access 
• describe a continuum of 
services/care that provides more patient 
focused care 
Clinical Applications of Tumor 
Markers. will be held on Friday, 
November 18, from 7:45 a.m. to 2:30 
p.m., in the Auditorium of Lehigh 
Valley Hospital, Cedar Crest & 1-78 .. 
Physicians, nurses, laboratory 
personnel, and other health 
professionals interested in tumor 
markers will benefit from the program. 
At the completion of this program, 
participants should be able to: 
• discuss the general application of 
tumor markers 
• explain the use of tumor markers as 
diagnostic and prognostic indicators for 
the oncology patient 
• describe the use of Cathepsin D 
Update on Lower Extremity and 
Lumbar Spine Problems: A Primary 
Care Approach will be held on 
Saturday, December 3, from 7:30a.m. 
to 1 p.m., in the Auditorium of Lehigh 
Valley Hospital, Cedar Crest & I-78. 
Continued on Page 14 
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Orthopedic surgeons, general 
practitioners, physicians' assistants, 
physical therapists, nurses, and other 
health professionals interested in an 
update on lower extremity and lumbar 
spine problems will benefit from this 
program. 
At the completion of this program, 
participants should be able to describe 
the symptoms, diagnosis, and treatment 
of hip, knee, ankle, foot, and lumbar 
spine problems in the general 
population. 
For more information regarding these 
programs, please contact Human 
Resource Development at 402-1210. 
Medical Grand Rounds 
Gastric Acid - To Suppress or Not 
Suppress will be presented by Steven 
M. Geller, D.O., Pulmonary Division, 
Osteopathic Medical Center, 
Philadelphia, Pa., on Tuesday, October 
18. 
Hepatitis C Virus (HCV) will be 
presented by M. Elaine Eyster, M.D., 
Professor of Medicine, and Chief, 
Division of Hematology, The Milton S. 
Hershey Medical Center, Hershey, 
Pa., on Tuesday, October 25. 
Medical Grand Rounds are held each 
Tuesday beginning at noon in the 
Auditorium of Lehigh Valley Hospital, 
Cedar Crest & I-78. 
For more information, contact the 
Department of Medicine at 402-8200. 
Department of Pediatrics 
New Methods of Contraception with 
Emphasis on Depo and Norplant will 
be presented by Paula Braverman, 
M.D., Director, Adolescent Medicine, 
St. Christopher's Hospital for 
Children, on October 28. 
Current Trends in Pediatric and 
Infant Cardiac Surgery will be-
presented by John Meyers, M.D., 
Hershey Medical Center, on November 
4. 
The above conferences will be held in 
the Auditorium of Lehigh Valley 
Hospital, 17th & Chew, beginning at 
noon. 
For more information, contact Beverly 
Humphrey in the Department of 
Pediatrics at 402-2410. 
Department of 
Psychiatry 
Clinical Assessment of Memory will · 
~ presented by Michael G. 
Lieberman, Ph.D., Clinical 
Neuropsychology, Center for Aging, 
University of Medicine and Dentistry, 
Stratford, N.J., on Thursday, October 
20, from noon to 1 p.m., in the 
Auditorium of Lehigh Valley Hospital, 
17th & Chew. As lunch will be 
served, pre-registration is requested. 
For more information or to register, 
contact the Department of Psychiatry at 
402-2810. 
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News from Health Promotion and Disease Prevention 
The Health Promotion and Disease 
Prevention Department of Lehigh 
Valley Hospital will present several 
free public lectures over the next few 
months. Sponsored by the Chronic 
Disease Education Committee of 
Lehigh Valley Hospital, the lectures 
include: 
Surviving Sinus Infections will be 
presented by Michael J. Gordon, 
M.D., otolaryngologist, on Tuesday, 
October 25, from 7 to 8:30p.m., in 
the Auditorium of Lehigh Valley 
Hospital, Cedar Crest & 1-78. 
Sufferers of sinus problems know very 
well how debilitating these infections 
can be, however, ·not all people 
suffering from sinus problems are 
aware of it. Perhaps you have a "cold 
or migraine that won't quit." A sinus 
disorder may be the cause. Learn 
about the diagnosis and treatment of 
sinus disorders, including endoscopic 
sinus s':lrgery. 
The Ergonomics of It All will be 
presented by Albert V. Fala, 
Occupational Hygienist, and Greg 
Salem, Exercise Specialist, on 
Wednesday, November 2, from 7 to 
8:30 p.m., in the Auditorium of 
Lehigh Valley Hospital, Cedar Crest & 
1-78. 
Ergonomics is about how you relate to 
your physical work areas -- both on the 
job and at home. "Fitting the activity 
to the person" helps prevent fatigue, 
stress, and injury. As part of this 
lecture, participants may complete a 
computerized "Personal Ergonomics 
Profile" and learn ways to increase 
their well-being and productivity. 
Beat the Holiday Blues will be 
presented by Michael W. Kaufmann, 
M.D., Chairperson, Department of 
Psychiatry, on Wednesday, November 
16, from 7 to 8:30 p.m., in the 
Auditorium of Lehigh Valley Hospital, 
Cedar Crest & 1-78. 
Holidays can be fun, but many times 
we feel too pressured to enjoy 
anything. In addition to everyday 
stresses, things are not made any easier 
by the holidays. Come and learn some 
creative ideas for setting priorities, 
dealing with the extra responsibilities, 
emotions and feelings so that you can 
relax and enjoy this wonderful season 
and perhaps make each day a little 
more manageable. 
In addition, the Health Promotion and 
Disease Prevention Department also 
offers numerous other classes and 
programs for nutrition and weight 
control, nicotine dependence, smoking 
cessation, stress management, and 
fitness. For more information or to 
register, call 402-CARE. 
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• For Sale or Lease -- Springhouse 
Professional Center, 1575 Pond Road. 
Ideal for physician's office. 
Approximately 2,500 sq. ft. 
• For Sales or Lease -- Medical/ 
Professional three-story office building 
at 1730 Chew Street, Allentown. 
Excellent condition with recent 
renovations. Approximately 6,800 
sq. ft. for single or multipre specialty 
practice. Includes long-term parking 
lease at Fairgrounds. Potential 
telephone and dictations systems. 
• For Sale -- Office building at 
Northeast corner of 1 9th and Turner 
Streets in Allentown. Upper level -
2,400 + sq. ft., large waiting room, 
two large consultation rooms, five 
exam rooms, etc. Lower level -
2,300 + sq. ft. Parking Jot for 16 
cars. 
• For Sale -- Medical office suite in 
the 1230 S. Cedar Crest Boulevard 
Medical Office Building. 1 ,225 sq. ft. 
• For Lease -- Office to sublet on 
Monday, Tuesday, Thursday, and 
Friday. 950 sq. ft. Common waiting 
area. Lakeside Professional Building, 
Quakertown. 
• For Lease-- Large, newly 
remodeled, completely furnished 
medical office space available for 
subleasing/time share at Cedar Crest 
Professional Park. Top of the line 
telephone system. Transcription and 
computer system with electronic 
billing available. 
• For Lease -~ Slots are currently 
available for the Brown Bag suite at 
Kutztown Professional Center. Ideal 
for satellite location. 
• For Lease -- Several time slots are 
available in the medical office building 
on the campus of Gnaden Huetten 
Memorial Hospital in Lehighton. 
• For Lease -- Medical-professional 
office space located on Route 222 in 
Wescosville. Two 1 ,000 sq. ft. 
offices available or combine to form 
larger suite. 
• For Lease -- Medical office space 
located in Peachtree Office Plaza in 
Whitehall. One suite with 1 ,500 sq. 
ft. (unfinished - allowance available), 
and one 1,000 sq .. ft. finished suite. 
• For lease -- Specialty practice time-
share space available in a 
comprehensive health care facility. 
Riverside Professional Center, 401 9 
Wynnewood Drive, Laurys Station. 
Half- or full-day slots immediately 
available. 
• For Lease -- Professional office 
space available in an established 
psychology and psychotherapy 
practice at 45 N. 1 3th Street, 
Allentown. Large, warm Victorian 
building in a relaxed atmosphere. 
Secretary and billing available and 
included in some leases. Furnished or 
unfurnished full offices and sublets 
available. Utilities included. 
For more information or for assistance 
in finding appropriate office space to 
meet your needs, contact Janet M. 
Laudenslager, Physician Relations 
Rep, at 402-9853. 
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WHO'S NEW 
The Who's New section of Medical 
Stqff Progress Notes contains an 
update of new appointments, address 
changes, newly approved privileges, 
etc. Please remember that each 
department or unit is responsible for 
updating its directory, rolodexes, and 
. approved privilege rosters. 
Medical Staff 
Appointments 
Michele D. Jones, DO 
Riverside Medical Associates 
(Thomas P. Harakal, MD) 
Riverside Professional Center 
Route 145, P.O. Box Q 
Laurys Station, PA 18059-0976 
(610) 261-1123 
Department of Family Practice 
Provisional Courtesy 
Arnold G. Salotto, MD 
Allen Neurosurgical Association, Inc. 
(Mark C. Lester, MD) 
1210 S. Cedar-Crest Blvd. 
Suite 1000 
Allentown, PA 18103-6208 
(610) 433-3143 
Department of Surgery 
Division of Neurosciences 
Section of Neuro Trauma 
Provisional Active 
Madalyn Scbaefgen, MD 
Southside Family Medicine 
(Neal J. Berkowitz, MD) 
141 E. Emaus Avenue 
Allentown, PA 18103-5899 
(610) 791-5930 
Department of Family Practice 
Provisional Active · 
Carolyn S. Scott, MD 
Mary T. Zygmunt, DO 
1575 Pond Road 
Suite 104 
Allentown, PA 18104-2250 
(610) 398-7848 
Department of Obstetrics and 
Gynecology 
Division of Primary Obstetrics and 
Gynecology 
Provisional Active 
Michael L. Zager, MD 
Lehigh Internal Medicine Associates 
(Jonathan W. Bortz, DO) 
2895 Hamilton Blvd. 
Atrium Building 
Allentown, PA 18104-6172 
(610) 439-0303 
Department of Medicine 
Division of General Internal Medicine 
Provisional Active 
Additional Privileges 
David L. Clair, MD 
Department of Surgery 
Division of Urology 
Active 
Collagen Implantation Privileges 
Laser Lithotripsy Privileges 
J. Patrick Kleaveland, MD 
Department of Medicine 
Division of Cardiology 
Active 
Coronary Rotoblator Privileges 
Jeffrey C. Snyder, MD 
Department of Medicine 
Division of Cardiology 
Active 
Stent Placement Privileges 
Continued on Page 18 
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Practice Name Change 
From David P. Steed, DPM 
to Dr. David P. Steed and Dr. Scott 
J. Lipkin 
Practice Change 
Brian L. Fellechner, DO 
no longer associated with Christopher 
G. Lynch, MD 
Address and Telephone 
Change 
Brian L. Fellechner, DO 
Allentown Osteopathic Medical Center 
1736 Hamilton Street 
Allentown, PA 18104 
( 610) 770-8395 
Christopher G. Lynch, MD 
4825 Tilghman Street 
Allentown, PA 18104 
(610) 398-9747 
(Effective 10/21/94) 
John S. Wheeler, MD 
5300 KidsPeace Drive 
Orefield, PA 18069-2098 
(610) 799-8000 
Leadership Appointments 
George I. Chovanes, MD 
Director, Central Nervous System Unit 
Mark D. Cipolle, MD 
Associate Chief, Division of Trauma 
Zev Elias, MD 
Chief, Section of Neuro Trauma 
Michael D. Pasquale, MD 
Associate Chief, Section of Surgical 
Critical Care 
Russell B. Puschak, MD 
Chief, Division of General Pediatrics 
Patrick B. Respet, MD 
Chief, Section of Ortho Trauma 
Michael Rhodes, MD 
Director, Surgical Critical Care 
Richard H. Snyder, MD 
Director, Medical Critical Care 
Resignations 
Gail E. Burgey, MD 
Department of Obstetrics and 
Gynecology 
Division of Primary Obstetrics and 
Gynecology 
Provisional Courtesy 
Nancy A. Urankar, MD 
Department of Medicine 





Monica Stauffer, RN 
Physician Extender 
Professional - RN 
(Cardiology Care Specialists- Dr. Morris) 
Danny Stein, PNP 
Physician Extender 
Professional - PNP 
(PEDS Clinic- Dr. Smith) 
Cynthia Ward, RN 
Physician Extender 
Professional - RN 




A Service of lEHI'?fVAILEY 
HOSPrnU.. 
Thyroid Testing: Which Test is First 
Which test should be ordered first 
when thyroid disease is suspected in an 
ambulatory patient? The answer is it 
depends. First are you thinking of 
hypo or hyperthyroidism, second what 
are the respective costs for the tests, 
third what is the turn-around-time and 
finally if the cost to the patient is 
"acceptable", then ordering both tests 
first may be the most convenient 
strategy. The American Thyroid 
Association suggests that the TSH 
complemented by the Free Thyroxine 
estimate (T7) "represents the best most 
efficient combination of blood tests for 
the diagnosis and follow-up of most 
patients with thyroid disorders". 
Alternatively, there is a trend to 
replace T4, T7, T3, Ff4, and TSH by 
single discriminating thyroid function 
test, namely the 3rd generation TSH. 
Although this approach is the most cost 
effective, not all published studies 
agree with the conclusion as applied to 
all clinical situations. Several 
thyroid disease states are reviewed here 
as to the various ordering strategies. 
Primary Hypothyroidism with 
Thyroid Enlargement 
A TSH first strategy is appropriate for 
primary hypothyroidism especially with 
the 3rd generation, highly sensitive, 
very precise TSH assay. 
Thyroid Function as Part of Pituitary 
Evaluation (Secondary 
Hyperthyroidism) 
TSH is of little or no value in this 
setting, since it can be low, normal or 
event slightly elevated. The best test 
to evaluate or follow up these patients 
is a Free T-4 or a Total T-4 with a T-3 
resin uptake (renamed TBI). 
SubClinical Hypothyroidism 
A TSH first strategy also detects 
subclinical hypothyroidism. However, 
a Total or Free T4 is also rec:luired 
here for the absolute diagnosis of this 
disease since the TSH is elevated and 
the T4 normal. Typical laboratory 
values for subclinical hypothyroidism 
are a TSH of 12.5 and a T4 of 7 .0. 
Subclinical hypothyroidism may be 
caused by chronic thyroiditis, atrophy 
of the thyroid, therapy for 
hyperthyroidism or the use of such 
drugs as lithium. Prophylactic 
hormone replacement is recommended 
for this group of patients with regular 
monitoring of TSH which should be 




The 3rd generation TSH assay can be 
used as the first test strategy because 
serum TSH levels approach zero 
( < 0.02 UIU/mL) in patients who are 
hyperthyroid. Some euthyroid patients 
may also present with slightly low 
levels of TSH but not <0.02. 
Therefore, a T4 and a T3 RIA should 
follow. Sick euthyroid patients (severe 
nonthyroidal illness) also can present 
with a low TSH. Where as the true 
hyperthyroid patient will always exhibit 
an unmeasurable TSH, sick euthyroid 
patients will have a. measurable TSH 
greater than 0.03 to 0.04 UIU/mL. 
Miscellaneous Thyroid Problems 
There are two additional situations 
where ordering TSH first is the 
preferred strategy: First, for pregnant 
patients, women receiving oral 
contraceptives or chronic renal disease 
where the accuracy of the T7 may be 
compromised by protein binding 
abnormalities; and secondly, to monitor 
the effectiveness of thyroid replacement 
therapy. Small changes in free T4 
. hormone concentrations trigger a 
corresponding 10 fold inverse change 
in TSH release. 
In summary, the jury is still out as to 
whether the TSH first strategy is 
appropriate in the ambulatory primary 
care setting where only 1% of patients 
suspected of having thyroid disease 
actually does. However the 3rd 
generation TSH tests are extremely 
valuable for confirmation particularly 
for hypothyroidism and new data may 
eventually show them to the "best" 
thyroid test for most all situations 
especially in this time of severe cost 
containment. 
Gerald E. Clement, Ph.D. 
Technical Director 
Clinical Laboratories 





P & T HIGHLIGHTS 
The following action were taken at the September 12, 1994 Pharmacy and 
Therapeutics Committee Meeting - James A. Giardina, Director of Pharmacy 
FORMULARY ADDITIONS· 
IV Nicardipine (Cardene, Wyeth-Ayent), 
was approved for a six month evaluation. It 
is indicated in the short term management of 
hypertension in critical care patients when 
oral therapy is not feasible. It is also being 
studied for use in the treatment aneurysmal 
subarachnoid hemorrhage. Nicardipine is 
a potent peripheral and coronary vasodilator, 
with greater selectivity for the vertebral, 
carotid, and coronary vessels. Nicardipine 
induces a dose dependent reduction is 
systolic, diastolic and mean blood pressure, 
as well as heart rate. Reflex tachycardia 
occurs which triggers a baroreflex response, 
which "results in a shortened effective and 
functional atrial refractory period, A V Node 
refractory period, and corrected sinus 
recovery time. The decrease in blood 
pressure is limited by the baroreflex 
· response. The elderly may experience a 
greater BP drop due to an impaired 
baroreflex response. IV Nicardipine avoids 
the first pass hepatic effect seen with oral 
administration. Rapid dose related increases 
in plasma concentrations are seen in the first 
2 hours and increase slowly thereafter and 
approach steady state in 24 - 48 hours. It is 
highly protein bound and rapidly and 
extensively metabolized in the liver. IV 
Nicardipine is contraindicated in patients 
with advanced aortic stenosis, given its 
afterload reducing effect. It should be given 
cautiously to patients with angina or CHF. 
Caution and reduced doses are 
recommended in patients with liver or renal 
impairment. The most common adverse 
reactions are related to its vasodilatation 
(headache, flushing, and warm feeling). 
Other reactions include hypotension, · 
tachycardia, nausea and vomiting. Phlebitis 
has been reported and the manufacturer 
recommends peripheral site changes every 
12 hours if the drug is given peripherally. 
IV Nicardipine has the same interactions as 
the oral form. Adequate & well controlled 
studies in pregnancy are lacking and it is not 
recommended for children or in nursing 
mothers. It is administered by slow iv 
infusion following a dilution of 25mg in 
250cc (O.lmg/cc) fluid. Nicardipine is 
compatible with most IV solutions except for 
Sodium Bicarbonate and Lactated Ringers. 
For gradual BP reduction, therapy should be 
started at Smg!hr (50cc/hr) and titrated in 
2.5mg or 25cc increments every 15 minutes 
up to a max of 15mg (150ml)/hr. For rapid 
BP reduction, the titration schedule should 
be increased every 5 min to the maximum 
dose or desired BP is achieved. Following 
achievement of BP control, the rate should 
be changed to 3mg (30ml)/hr and adjusted 
as needed to maintain the desired level of 
control. Oral therapy with nicardipine 
should be started 1 hour prior to infusion 
discontinuation or simultaneously if another 
agent is chosen. Table I shows cost/dose and 
cost/day for the commonly used BP 
controlling agents. 
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Salmeterol (Serevent, A&H), is a structural 
analog of albuterol indicated for use in the 
long term maintenance treatment of asthma, 
and prevention of bronchospasm in patients 
over 12 with reversible obstructive airway 
disease. It has a longer duration of action 
and is more potent than albuterol. Its onset 
of action is within 5 - 15 min, with a 
duration of at least 12 hrs. Its longer 
duration is not explained by its plasma half 
life which is similar to albuterol's. Because 
of its slow onset, salmeterol should not be 
used in acute attacks. Salmeterol's side 
effects are similar to other beta-agonist 
bronchodilators and include HR & BP 
increase, palpitations, headache, cough and 
tremor. Salmeterol has not been adequately 
studied in pregnancy, nursing mothers and 
children under 12. Studies to date seem to 
show similar safety and efficacy in geriatric 
as well as younger patients. Salmeterol 
should be beneficial in patients with 
nocturnal asthma, who require regular 
treatment with short acting beta agonists. It 
should also be useful in patients who 
experience exercise induced asthma and 
should be used 30 - 60 minutes before 
exercise. Salmeterol is usually dosed at 2 
inhalations (21mcg/puft) twice daily, as 
close to twelve hours apart as possible. 
Salmeterol 100mcg may be necessary in 
some patients with severe asthma. 
Salmeterol may be given together with a 
corticosteroid. A general recommendation 
is for the beta agonist to be used prior to the 
steroid. Patients may also need a 
prescription for a short acting beta agonist 
like albuterol for treating any acute 
exacerbations. Salmeterol costs $25.17 for 
a 60 dose (2 week) compared to $6.01 for 
Albuterol 80 dose (10 day). 
FORMULARY 
REJECTION 
Azithromycin (ZithroiiUlX, Pfizer), is an 
azalide antibiotic, which differs only slightly 
from erythromycin and clarithromycin 
(Biaxin, Abbott). Azithromycin is a long 
acting and expensive agent, which appears 
most suited to the outpatient setting at this 




The committee approved several revisions to 
the dose substitution nomogram. These 
changes are supported by literature which 
shows that Smg & 24mg doses are equally 
efficacious compared to 32mg for mild & 
moderately emetogenic chemotherapy, 
respectively. The literature supports using 
the 32mg dose for highly emetogenic 
regimens. Table 2 shows the critical 
information on dosing and cost and Table 3 
shows the relative emetogenic potential of 
the various chemotherapeutic agents. The 
dose standardization nomogram is useful in 
reducing the waste potential from custom 
ordered mg/kg doses. 
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Table 1: Commonly Used Agents for BP Control 
Agent Cost Per Unit Cost/Day 
Nicardipine $16.50 per 25mg ampule $80-$264 
Nitroprusside $0.75 per 50mg vial $1.50 - $7 .so 
Hydralazine $1.00 per 20mg vial $26 
Labetolol $27.20 per 200mg vial $41.20 -
Enalaprilat $8.80 per 1.2Smg $35.20-$70.40 
OraJ/Ngt Nifedipinc $0.16 - $0.30 per cap 
Oral/Ngt Amlodipine $0.92 per tab 
Oral/Ngt Clonidine $0.01 per tab 
Oral/Ngt ACEI's $0.50- $1.30 per tab 
Table 2: On4ansetron Dose and Cost .,. .. ·····":"tt·~-~~, 
Dose Ordered Previous Dose Current Dose Cost/Current .. 
Dispensed Dispensed Dose 
< 8mg Dose ordered 4mg $ 17.45 
> 8mg & <_12mg 10mg Smg $34.90 
> 12mg & < 20mg Dose ordered 16mg $69.80 
> 20mg & < 28mg· Dose ordered 24mg $104.7.0 
> 28mg 32mg 32mg $139.60. 
Table 3: Emetogenic Potential of Selected Antineoplastic Agents 
/ HIGH MODERATELY HIGH MODERATELY LOW " MODERATE LDW (>In) (ID·In) (30.10,.) (10·~) (elK) 
Connudne a:zoo"''l Cannullino <IOomg Altrotemlno Bleomycin luaullen 
~ 
Claplalln a 7Smg Claplalln <7Smg Aaporoglnan Cpterablno 1120mg Chlorambucil 
Cycloplloapllamlclo >1gm Cycioplloopllomlclo • tgm Aaadtidlno Doxorubicin • IOmg Cycloplloapllamldo (Oral) 
Cytarablno > 1 gm Cytarobl111 150fng·1 gm Carboplalin EIOpooldo Ttuoguanine 
Docorbolillo aiiOOmg Docorbolillo cSOOmg Cycloplloaplwnldo < lgm Fludarabine Vincrishne ..... :· 
Doctinontycln a SOOmcg DoctiiiDftlycin <SOOrncg Daunorubldn Fluorourodl ctgm 
Lomuatlno aeomg Doaorubldn a 7Smg Doxorubicin >20"'11 <7Smg Hydrooyuroa Alldrogent 
looloclllorllhomlno LomuoUne <IOmg fluorouracil a tgm Molpllalon Cortteoateroidl 
P11110ololin Motholroaato a250mg ldorubicln Mercaptopurine l••····"· 
S troptozocln Mitomycin 1 Molhotroallo atOOrng <250mg Methotr••••• c tOOmg ,., ........ , 
Pllcomycln Mitomycin 7 Tenipoaida 1 
Procarbazine Mltoa•ft&rone Tlllotopo 
. •· .Tonlpoaidot 7 . Vlnblooljno I ...... -. .. , 
References: Figg WD, Figg JM. US PHARMACIST, 1994: 19(6):54-82, 
Craig JB, et al. AM J MED SCI. 1987; 29:34-44 . Page 23 





In July and August, 20 patients received 
alteplase with 15 receiving standard (STD 
Tx) dosing and five receiving accelerated 
(ACCEL Tx) dosing. Both patients less 
than 65 Kg were weight dosed (SID Tx). 
One patient (STD Tx) experienced bleeding, 
which didn't require transfusion. Fourteen 
patients went on to either PTCA or CABG. 
No serious bleeds or other serious adverse 
clinical events have been noted since 
monthly monitoring was reinstituted. 
ANERGY PANEL 
REVISION 
Tetanus Toxoid Fluid will replace 
Trichophyton in the 4 test anergy battery 
when an anergy panel is ordered. The other 
three tests are PPD 5TU, Mumps, and 
Candida. Trichophyton has had a low 
reactivity thereby negating its value to test 
cellular immunity. Tetanus toxoid fluid is 
given as a dilute solution in a dose of O.lcc 
and is not interchangeable with Tetanus 
Toxoid Adsorbed, which is used for tetanus 
prevention. In patients with confirmed 
tetanus allergy, the three test panel without 
tetanus will be used. 
pt\091294.hi 
PHARMACY HOURS 
AT 17 & CHEW 
Effective September 19, the Pharmacy 
Department at 17 & Chew will close at 2200 
hours daily instead of 2400 hours. This 
change better matches resources to service 
utilization. The quality of the pharmacy 
services will be maintained through a 
thorough review of the night closet contents 
(this closet contains a small supply of the 
most commonly used as well as emergency 
products. For information or medications, 
which are unavailable in the night closet and 
are needed before morning, a pharmacist 
from CC & 1-78 is available. For on site 
services, a 17 & Chew pharmacist remains 
available on a call in basis. 
FELBAMATE 
ALERT 
The committee was updated on the status of 
this drug alert. Worldwide, 21 patients 
have developed aplastic anemia with three 
fatalities. The Clinical Pharmacy Service 
has identified all inpatients who received 
felbamate and informed their attending 
physicians of the manufacturer and the FDA 
recommendations. This recommendation is 
that patients be withdrawn from Felbamate, 
but it recognizes that Felbamate may be an 
essential agent to maintaining a patient in a 
seizure free state. For this reason, 
felbamate will remain on the market with a 
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